Skip to main content

Medtronic Inc(MDT-N)
NYSE

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time

Medtronic receives FDA approval for Inceptiv™ closed-loop spinal cord stimulator

Newswire.ca - Fri Apr 26, 6:56AM CDT

Closed-loop sensing capability instantly and automatically adjusts therapy while treating chronic pain

DUBLIN, April 26, 2024 /CNW/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced that the U.S. Food and Drug Administration (FDA) has approved the Inceptiv™ closed-loop rechargeable spinal cord stimulator (SCS) for the treatment of chronic pain. Inceptiv is the first Medtronic SCS device to offer a closed-loop feature that senses biological signals along the spinal cord and automatically adjusts stimulation in real time, keeping therapy in harmony with the motions of daily life.

Read more at newswire.ca

Provided Content: Content provided by Newswire.ca. The Globe and Mail was not involved, and material was not reviewed prior to publication.

More from The Globe